Live Breaking News & Updates on Aprea Therapeutic

Stay updated with breaking news from Aprea therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FY2028 EPS Estimates for Aprea Therapeutics, Inc. (NASDAQ:APRE) Cut by Analyst

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Analysts at Wedbush reduced their FY2028 earnings per share estimates for Aprea Therapeutics in a research report issued to clients and investors on Tuesday, May 14th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of $0.77 per share for the year, down from […] ....

Berndr Seizinger , Aprea Therapeutics Company Profile , Aprea Therapeutics Inc , Aprea Therapeutics , Free Report , Aprea Therapeutic , Get Free Report , Director Bernd , Aprea Therapeutics Daily , Nasdaq Apre , Earnings Estimates ,

Aprea Therapeutics, Inc. (NASDAQ:APRE) Expected to Post Q1 2025 Earnings of ($1.00) Per Share

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Stock analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of Aprea Therapeutics in a research note issued to investors on Tuesday, March 26th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($1.00) per share for the quarter. Wedbush […] ....

Berndr Seizinger , Geode Capital Management , Securities Exchange Commission , Royal Bank , Aprea Therapeutics Inc , Millennium Management , Vanguard Group Inc , Aprea Therapeutics Company Profile , Aprea Therapeutics , Free Report , Aprea Therapeutic , Director Bernd , Exchange Commission , Capital Management , Get Free Report , Aprea Therapeutics Daily ,

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made. ....

Aprea Therapeutics , Aprea Therapeutic , Aprea Therapeutic Cash Burn , Free Cash Flow ,

Aprea Therapeutics, Inc. to Post Q3 2023 Earnings of ($1.04) Per Share, HC Wainwright Forecasts (NASDAQ:APRE)

Aprea Therapeutics, Inc. to Post Q3 2023 Earnings of ($1.04) Per Share, HC Wainwright Forecasts (NASDAQ:APRE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sio Capital Management , Aprea Therapeutics Inc , Millennium Management , Capital Management , Aprea Therapeutics Company Profile , Aprea Therapeutics , Free Report , Aprea Therapeutic , Therapeutics Trading Down , Get Free Report , Street Group , Aprea Therapeutics Daily ,

Head-To-Head Analysis: Corcept Therapeutics (NASDAQ:CORT) & Aprea Therapeutics (NASDAQ:APRE)

Head-To-Head Analysis: Corcept Therapeutics (NASDAQ:CORT) & Aprea Therapeutics (NASDAQ:APRE)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Josephk Belanoff , Corcept Therapeutics Inc , Corcept Therapeutics , Aprea Therapeutics , Aprea Therapeutic , Given Aprea Therapeutic , Menlo Park ,